Changing the Game in
Drug Development and Patient Access

Model-informed Drug Development
Health Economics/Outcomes Research & Real World Evidence
Regulatory Science, Strategy & Services

Certara Supported 90+ Percent of US FDA Novel New Drug Approvals for Fourth Consecutive Year

Certara’s Simcyp PBPK M&S Technology Achieves First FDA Virtual Bioequivalence Approval for ‘Complex’ Generic Drug

Our Mission

Enable superior drug development and patient care decision-making through model-informed drug development, regulatory science, real world evidence and knowledge integration, thus optimizing R&D productivity, commercial value and patient outcomes.

Latest from Certara

Blog

In the Press

Webinars